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Summary Several studies suggest that in individuals with substantial previous
exposure to malaria, co-infection with multiple clones of Plasmodium falciparum
can protect against subsequent clinical malaria attacks. Other studies, mainly of
individuals with little previous exposure, found the converse relationship. To test
whether acquisition of such cross-protection tracks the acquisition of clinical immu-
nity in general, 610 Tanzanian children aged 0—6 years were enrolled in a nine-month
prospective study of the risk of morbidity in relation to parasitological status and
merozoite surface protein 2 genotypes on enrolment. Prevalence of parasitaemia
and multiplicity of infection increased with age. In the ﬁrst year of life, the inci-
dence of clinical malaria was almost three times higher in children with parasites at
baseline than in those without. In older children, baseline P. falciparum infections
appeared to protect against both parasitaemic and non-parasitaemic fever episodes.
In children aged less than three years, baseline multiple infection tended to be as-
sociated with higher prospective risk of clinical malaria than single infection while
in children aged more than three years the converse was found, but these effects
were not statistically signiﬁcant. These results provide further evidence that rela-
tionships between asymptomatic malaria infections and clinical malaria change with
cumulative exposure.
© 2004 Royal Society of Tropical Medicine and Hygiene. Published by Elsevier Ltd.
All rights reserved.
* Corresponding author. Tel.: +41 61 2848 117;
ax: +41 61 2718 654.
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1. Introduction
In areas highly endemic for malaria, many individ-
uals are infected simultaneously with several Plas-
modium falciparum clones. The term multiplicity
035-9203/$ — see front matter © 2004 Royal Society of Tropical Medicine and Hygiene. Published by Elsevier Ltd. All rights reserved.
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of infection (MOI) has been used to describe the
number of concurrent infections per carrier. Mul-
tiplicity of infection is determined by genotyping
highly polymorphic marker genes and reﬂects the
number of different genotypes detected. In areas
of high endemicity, multiplicity depends on the age
of the host (Ntoumi et al., 1995; Smith et al., 1999a)
and on the transmission intensity (Arnot, 1998). In
Idete, Tanzania, mean MOI in asymptomatic chil-
dren aged 3—7 years was ﬁve infections per carrier
(Beck et al., 1997). In contrast, in children aged
less than one year in the same village, mean multi-
plicity was only two infections per child (Felger et
al., 1999).
A number of studies have found relationships be-
tween MOI and the risk of malaria morbidity. Sev-
eral studies of partially immune children have found
that multiple malaria infections are associated with
reduced incidence of clinical episodes of P. falci-
parum (Al Yaman et al., 1997a; Beck et al., 1997;
Farnert et al., 1999). A study in Sa˜o Tome´ found
that the apparent protection extended also to non-
malaria fever episodes (Muller et al., 2001). Other
studies, such as those of infants in Idete (Felger et
al., 1999; Smith et al., 1999a), of children aged less
asite genotypes and multiplicity varied with age in
the baseline survey. We then tested whether para-
site density, multiplicity of infection, or a speciﬁc
msp2 allelic family of P. falciparum were associ-
ated with the risk of subsequent febrile episodes
and how these relationships varied with age.
2. Materials and methods
2.1. Study site
The study was conducted in Ifakara town, Kilo-
mbero District, Tanzania during the rainy season,
starting in March 1998. The Kilombero district is
mostly an area of intense and perennial malaria
transmission, predominantly P. falciparum (Smith
et al., 1993) with Anopheles gambiae and A. funes-
tus as the two main vectors. Prevalence of P. falci-
parum infections shows no marked seasonality, but
mosquito densities, exposure and incidence of clin-
ical malaria episodes in young children vary over
the year. A decade ago, the average entomological
inoculation rate (EIR) recorded in nearby rural ar-
eas was more than 300 infectious bites per person
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athan three years in western Kenya (Branch et al.,
2001), of children in Ghana (Ofosu-Okyere et al.,
2001), and of individuals in relatively low transmis-
sion settings in the Sudan (Roper et al., 1998) and
Mozambique (Mayor et al., 2003) have found that
multiple infections were a risk factor for clinical
malaria attacks.
To explain these diverse results, we have
previously proposed that cross-protection against
clinical malaria by concomitant infections may be
characteristic of the semi-immune host, in contrast
to individuals with less immunity, in whom each ad-
ditional infection adds to the risk of a clinical attack
(Smith et al., 1999b). This implies that the patterns
would vary with the degree of malaria endemicity.
However, these apparent relationships are also in-
ﬂuenced by many other factors, which differ be-
tween studies, including survey design and patterns
of seeking healthcare (Branch et al., 2001; Muller
et al., 2001). To examine how the effect of MOI
varies as clinical immunity is acquired, we carried
out a cohort study of 610 children in Ifakara, Tanza-
nia, spanning the whole age range (from birth to six
years) over which clinical immunity to P. falciparum
was thought to develop in this area.
We carried out an initial cross-sectional survey
of the cohort. Fever episodes were then recorded
via a passive case detection system for the follow-
ing nine months. As for previous studies, we used
the highly polymorphic merozoite surface antigen 2
(msp2) as a molecular marker to examine how par-er year (Smith et al., 1993). However, recent ﬁeld
urveys have found much lower levels of malaria
ransmission, in particular in Ifakara town where an
nnual EIR of 29 infective bites per person has been
stimated (Drakeley et al., 2003). Ifakara town is
he site of the St Francis Designated District Hos-
ital (SFDDH), which provides primary health care
acilities for the population of the town, as well as
cting as a referral hospital for the whole district.
ost of Ifakara town has the characteristics of a
eri-urban area with a high population density, but
ith areas of subsistence agriculture interspersed
etween the houses. Houses are constructed ei-
her of traditional-style mud bricks and thatch or
f baked bricks with galvanized iron roofs.
.2. Cohort recruitment and survey
rocedures
comprehensive list of balozis (ten-cell-leaders
ho are responsible for approximately 10 house-
olds) was used as a sampling frame. A random
ample of 610 children (50% male) aged 0—6 years
mean age 2.9 years), stratiﬁed into one-year age
roups, was selected by randomly sampling from
he list of balozis and recruiting one child at ran-
om from each age group within the area covered
y each balozi. Children were only recruited to the
tudy after the study was explained to their parents
nd the latter had signed a letter of consent written
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in Kiswahili. Parents were invited to bring their chil-
dren to the Maternal and Child Health (MCH) clinic
of the SFDDH where two blood slides for micro-
scopic detection of malaria parasite were collected
from each child, and a ﬁnger-prick blood sample
collected in an EDTA microtainer. Research and eth-
ical clearance for this study was obtained from
the local (Ifakara) ethical committee and subse-
quently from the Tanzanian Commission for Science
and Technology (UTAFITI), based on the recom-
mendation of the Medical Research Coordination
committee of the National Institute for Medical
Research (NIMR). Children who were already par-
ticipating in a health intervention trial were not re-
cruited.
2.3. Case detection and treatment
Children enrolled in the study were offered free
treatment at SFDDH and were followed-up over
nine months until January 1999 by a passive case
detection system at the MCH clinic or the outpa-
tient clinic of SFDDH. All children reporting sick
were seen by a project clinical ofﬁcer. A ﬁnger-
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2.5. Genotyping
Blood pellets were transferred to IsoCodeTM Stix
PCR template preparation dipstick (Schleicher and
Schuell, Dassel, Germany) for storage, transport
and DNA isolation (Henning et al., 1999). All par-
asites in microscopically-positive children, both in
the baseline surveys and from sick children, were
genotyped by PCR—RFLP using the msp2 of P. falci-
parum as a marker gene. In addition, a 20% ran-
dom sample of the microscopy-negative samples
from the baseline survey was also analysed by PCR.
PCR—RFLP genotyping of msp2 was performed as
described by Felger and Beck (2002). The increased
sensitivity of detection by PCR resulted in a num-
ber of previously undetected infections. By assum-
ing the positivity rates measured for this 20% of the
microscopy-negative samples to apply to all other
microscopy-negative samples, the overall preva-
lence and multiplicity by PCR were estimated.
2.6. Data analysis
Prospective analysis considered the time to the
ﬁrst fever episode, ﬁrst clinical malaria and
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mrick blood sample was collected in an EDTA micro-
ainer and a blood slide was prepared. Those with
lide-positive malaria were given a standard treat-
ent of chloroquine (25mg/kg) for three days or
ulfadoxine—pyrimethamine, in line with national
olicy. Those with a packed cell volume <25% re-
eived iron supplementation (6mg/kg daily) for two
eeks and a treatment dose of antimalarial, ac-
ording to hospital guidelines.
For the purposes of the present analysis, febrile
pisodes were deﬁned as those with axillary tem-
eratures >37.4 ◦C and clinical malaria episodes
ere febrile episodes subsequently conﬁrmed by
icroscopy to be P. falciparum-positive. The small
ample size precluded any formal deﬁnition of clin-
cal malaria cases using parasitaemia cut-offs >0.
.4. Blood slide analysis
hick and thin blood ﬁlms were air-dried and
tained with Giemsa’s stain for microscopy. Par-
site density was assessed by counting the num-
er of asexual stage parasites per 200 leucocytes.
he number of parasites relative to the leucocyte
ount was converted to parasites per microlitre of
lood by assuming a leucocyte count of 8000/l.
tandard quality control procedures established in
he Ifakara laboratory were applied (Alonso et al.,
994).he ﬁrst non-parasitaemic fever episode, using
aplan—Meier analysis of times to episodes. The
nalysis was done using Epi-Info, version 6 (CDC,
tlanta, GA, USA) and SAS, version 8.2 (SAS Insti-
ute Inc., Cary, NC, USA).
. Results
.1. Age-dependence of parasitological
ndices at baseline
t baseline, 172/610 (28%) of the children were
ositive for P. falciparum by microscopy, and 170
f these were conﬁrmed positive by PCR. In ad-
ition, 15/88 microscopy-negative blood samples
ested were found to be positive by PCR. By assum-
ng this proportion to hold for the untested samples,
e estimated the overall PCR positivity as 40%.
eometric mean parasite density of microscopy-
ositive samples was 1350.2 parasites/l (95% CI
040.4—1752.3).
Parasite prevalence increased with age, whether
ssessed by microscopy or by PCR (Figure 1).
he density of P. falciparum in microscopy-
ositive slides peaked in children aged two years
Figure 2A).
The alleles of the marker gene msp2, can be
rouped according to their central dimorphic do-
ain into either the FC27 or the 3D7/Indochina 1
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Figure 1. Prevalence of Plasmodium falciparum in Tanza-
nian children at baseline, by age. () Proportion of slides
positive by microscopy. (©) Proportion of microscopy-
negative samples positive by PCR. () Estimated overall
prevalence by PCR.
allelic family. A total of 230 FC27 family infections
and 291 3D7 family infections were detected in the
samples positive by PCR at baseline while 3D7-type
alleles accounted for 19/26 of the infections found
in samples negative by microscopy, but positive by
PCR, suggesting that 3D7-type parasites tend to give
infections with lower densities. This conclusion was
supported by the ﬁnding that parasite density was
correlated with the proportion of infecting alleles
belonging to the FC27 family (Spearman’s r = 0.19,
P = 0.05).
Mean multiplicity of infection was 2.9 concur-
rent infections per carrier in samples positive by
both microscopy and PCR. Mean multiplicity in
microscopy-negative, but PCR-positive blood sam-
ples was 1.7 infections. These numbers led to the
estimated overall mean multiplicity of 2.6 infec-
tions.
The parasite density was positively correlated
with the overall multiplicity, with the strongest cor-
relation in the youngest children and a steady de-
cline in the correlation with age (Figure 2B). This
pattern was accounted for by the effect of 3D7-
type infections. The correlation of densities with
the FC27 multiplicity did not show a simple rela-
Figure 3. Multiplicity of Plasmodium falciparum infec-
tion in Tanzanian children, by age. () Overall multiplic-
ity. () Multiplicity of FC27 infections. (©) Multiplicity
of 3D7 infections.
Multiplicity increased until the age of three years
and after that remained stable (Figure 3). The in-
crease was mainly accounted for by FC27 family
parasites, which were infrequent in children aged
less than two years (Figure 3).
3.2. Morbidity follow-up by passive case
detection
Twelve of 610 children had a febrile episode at
enrolment, and during the nine-month period of
follow-up, 499 of these 610 children reported sick
to the hospital or MCH clinic. Of these children,
70 presented subsequently with one or more clin-
ical malaria episodes, but did not report with
non-parasitaemic febrile illnesses. A further 169
presented with non-parasitaemic fevers but not
with clinical malaria, and 46 experienced clinical
malaria episodes and non-malaria fevers at differ-
ent times.
The overall incidence of fevers decreased
steeply with age; however, the incidence of P. fal-
ciparum positive fevers showed only a little age-
dependence, with a maximum in children aged
two years. Consequently, fever episodes without
c
c
l
f
F
a
mtionship with age (Figure 2B).
Figure 2. Age dependence and parasite densities in Tan-
zanian children. (A) Geometric mean parasite density
±95% CI. (B) Spearman’s correlation between parasite
density and multiplicity. () Overall multiplicity. () Mul-
tiplicity of FC27 infections. (©) Multiplicity of 3D7 infec-
tions.oncomitant parasitaemia predominated in those
hildren who were aged less than two years at base-
ine, while parasitaemic episodes were relatively
requent in older children (Figure 4).
igure 4. Incidence of fever in Tanzanian children, by
ge. () All fevers. (©) Non-malaria fevers. ( ) Clinical
alaria.
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The main objective of the analysis was to ex-
amine how the incidence of clinical malaria de-
pended on the parasitological status at baseline.
The effects varied with the age of the children.
In the youngest age groups, malaria parasites at
baseline were a risk factor for subsequent clini-
cal attacks, while in older children, baseline par-
asitaemia appeared to be a protective factor, so
that children aged more than three years who were
parasite-negative at baseline were more likely to
report clinical malaria episodes than their initially
parasite-positive contemporaries (log-rank test of
the effect of positivity on survival times, adjusted
for age, 2 = 1, d.f. = 0.7, P = 0.4; interaction be-
tween age and positivity effect, 2 = 1, d.f. = 11.5,
P < 0.001). This strong age trend in the relative risk
associated with parasitaemia at baseline (Figure 5)
was not seen for aparasitaemic fever episodes. Par-
asitaemia at baseline was also associated with re-
duced risk of non-parasitaemic fevers in all but the
youngest children.
The risk associated with multiple infections at
baseline was compared with that of single clone
infections, to test whether the diversity of co-
infecting parasites would modify the degree of
multiple infections had less risk of non-malaria
fevers than singly infected children in the same age
group, but this effect was not evident in older chil-
dren (log-rank 2 = 1, d.f. = 4.9, P = 0.02 for the
overall effect of multiple infections adjusted for
age; 2 = 1, d.f. = 13.7, P < 0.001 testing whether
this effect is age dependent).
3.3. Characteristics of clinical malaria
episodes
Two hundred and forty-seven blood samples from
febrile patients, collected on attendance at the
passive case detection facilities, were analysed by
PCR. Ninety-six of these were positive and geno-
typed at the msp2 locus. Forty-four of the positive
samples contained only 3D7 alleles, 43 mixed family
infections and 9 FC27-type parasites only. The den-
sities in the FC27-type infections were higher than
in infections by both families or by 3D7 alleles only
(FC27 family, geometric mean 7631 parasites/l,
95% CI 460—125 000; 3D7 family, geometric mean
534 parasites/l, 95% CI 135—2105; mixed infec-
tions, geometric mean 788 parasites/l, 95% CI
185—3362). The number of children fromwhom par-
a
p
w
g
g
s
4
T
t
s
o
o
l
a
i
s
a
C
w
u
r
h
(
r
s
isites were typed both at baseline and from a sam-
le collected from a subsequent clinical episode
as too small to allow any deﬁnite conclusions re-
arding the effect of baseline genotypes on the
enotypes of parasites when the individual became
ick.
. Discussion
his study was designed to test whether infec-
ion status at baseline would determine the sub-
equent malaria incidence and how the acquisition
f clinical immunity to malaria (and hence the age
f the host) modiﬁes this relationship. Our ear-
ier suggestion was that in semi-immune individu-
ls exposed to continual infection, P. falciparum
nfections stimulate short-term cross-protective re-
ponses, and, hence, hosts with multiple infections
re at relatively low risk of subsequent morbidity.
onversely, in groups with little previous exposure,
e suggested that malaria infection, and in partic-
lar high multiplicity of infection, is a marker of
ecent inoculations. These hosts, therefore, have
igher risk of further infections and clinical attacks
Smith et al., 1999b).
This hypothesis is difﬁcult to test because cor-
elations between clinical episodes and infection
tatus can easily arise as a result of confound-
ng factors such as heterogeneous use of healthprotection or risk associated with infection per
se (Table 1). In children aged less than three
years, there was a tendency for multiple infec-
tions to be associated with higher prospective risk
of clinical malaria, but in children aged more
than three years, the tendency was for multi-
ple infections to appear to protect against clin-
ical malaria. However, none of the effects of
multiplicity on clinical malaria incidence were
statistically signiﬁcant. Similarly, there were no
signiﬁcant effects of the allelic families of infect-
ing parasites on the risk of subsequent clinical
malaria when the potentially confounding effects
of the age of the host were allowed for (data not
shown).
In contrast to the effects on clinical malaria
episodes, children aged less than three years with
Figure 5. Effect of Plasmodium falciparum positivity at
baseline on incidence of fever in Tanzanian children. ()
All fevers. (©) Non-malaria fevers. ( ) Clinical malaria.
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3) facilities (Branch et al., 2001), or host genetic
polymorphisms that affect the host response to
infection. Therefore, we designed our study to
compare different age groups within the same
population. Since it is unlikely that the effects
of such confounding factors are age dependent,
the differences with age in the relationships be-
tween risk of clinical attacks and parasitological
status are most likely due to effects of acquired
immunity.
The results were broadly consistent with
previous ﬁndings from Kilombero valley, in that pre-
existing infections seemed to confer some protec-
tion against clinical episodes in the older, but not
the younger children, and the correlation between
parasite density and multiplicity (which also indi-
cates the degree of interaction between clones) de-
creases with the age of the host. However, the level
of P. falciparum endemicity in Ifakara town proved
to be much lower than had been expected on the
basis of previous studies (Charlwood et al., 1998;
Smith et al., 1993). It is now apparent that, owing
to ongoing malaria control activities and urbaniza-
tion, there has been a sustained decrease in trans-
mission in this area in the last decade (Schellenberg
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at al., 2003). A recent study reported an EIR of as
ow as 29 (95% CI 19—44) bites per annum (Drakeley
t al., 2003). As a consequence of the lower trans-
ission rate our study had less power than ex-
ected and even the oldest children in our study
ad experienced much less P. falciparum expo-
ure than those children elsewhere in whom mul-
iple infections appeared to be protective (Al Ya-
an et al., 1997a; Beck et al., 1997; Contamin
t al., 1996; Farnert et al., 1999; Robert et al.,
996). The mean multiplicity in our study was lower
han in most of these studies. The children in the
lder age group with multiple infections were too
ew for it to be possible to demonstrate whether
he multiplicity conferred any signiﬁcant protec-
ion.
The different contributions of the two allelic
amilies of msp2, both to the load of asymptomatic
nfections and to the clinical episodes also broadly
upported ﬁndings from other studies. In particu-
ar, the increase in the proportion of FC27 family
nfections with age and the higher parasite densi-
ies associated with this family conﬁrm the previ-
us ﬁndings from both Papua New Guinea (Felger
t al., 1994) and Tanzania (Beck et al., 1999),
hich suggested that the alleles of the FC27 fam-
ly were more successful in evading the host’s im-
une response. In support of this, both a case con-
rol study, and a vaccine ﬁeld trial in Papua New
uinea found that FC27-type alleles were strongly
ssociated with malaria morbidity (Engelbrecht et
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al., 1995; Genton et al., 2002). Another study at
the same site found that asymptomatic 3D7 family
infections appeared to protect against subsequent
morbidity, but FC27 family infections did not (Al
Yaman et al., 1997b). In contrast, a study in Sene-
gal failed to ﬁnd any association betweenmsp2 type
and disease severity (Robert et al., 1996).
As a possible mechanism underlying such asso-
ciations with morbidity, Engelbrecht et al. (1995)
suggested that epitopes from FC27-type MSP2might
elicit strong but less protective antibody responses
(the ‘smokescreen’ hypothesis), thus enabling in-
creased proliferation and higher densities of para-
sites with a FC27-type MSP2.
Several other studies have found apparent
protection conferred by P. falciparum infections
against non-malaria fevers (e.g. Muller et al.,
2001), but others did not ﬁnd such protection (Al
Yaman et al., 1997a). These discrepancies lend
themselves to several possible interpretations.
Malaria infections may genuinely reduce suscep-
tibility to non-malaria fevers by modulating non-
speciﬁc immune responses. However, non-malaria
fevers will be under-recorded in initially para-
sitaemic individuals because infecting malaria par-
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